Details for Patent: 9,283,280

Which drugs does patent 9,283,280 protect, and when does it expire?

Patent 9,283,280 protects TOSYMRA and is included in one NDA.

This patent has sixty-seven patent family members in twenty-eight countries.

Summary for Patent: 9,283,280

Title:	Compositions for drug administration
Abstract:	The present invention provides compositions and methods and for increasing the bioavailability of therapeutic agents in a subject, as well as compositions and methods for providing migraine pain relief. The compositions include at least one alkyl glycoside and at least one therapeutic agent, such as a 5-HT receptor agonist, wherein the alkylglycoside has an alkyl chain length from about 10 to about 16 carbon atoms.
Inventor(s):	Maggio; Edward T. (San Diego, CA)
Assignee:	Aegis Therapeutics, LLC (San Diego, CA)
Application Number:	13/893,219
Patent Claim Types: see list of patent claims	Composition; Delivery;

Drugs Protected by US Patent 9,283,280

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Tonix Meds	TOSYMRA	sumatriptan	SPRAY;NASAL	210884-001	Jan 25, 2019		RX	Yes	Yes			Y

International Family Members for US Patent 9,283,280

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2009329952
Australia	2011317202
Australia	2019217643
Australia	2021254650